We are live on ! Find out more
SMTI icon

Sanara MedTech

47 hedge funds and large institutions have $28.6M invested in Sanara MedTech in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 21 increasing their positions, 13 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 13

45% more capital invested

Capital invested by funds: $19.8M → $28.6M (+$8.81M)

9% more funds holding

Funds holding: 4347 (+4)

0.7% more ownership

Funds ownership: 7.44%8.14% (+0.7%)

Holders
47
Holders Change
+4
Holders Change %
+9.3%
% of All Funds
0.69%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
21
Reduced
13
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$8.42M +$765K +23,842 +13%
Vanguard Group
2
Vanguard Group
Pennsylvania
$5.76M +$141K +4,403 +3%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$3.07M +$126K +3,939 +6%
State Street
4
State Street
Massachusetts
$2.19M +$57.4K +1,789 +3%
Northern Trust
5
Northern Trust
Illinois
$1.27M +$5.2K +162 +0.5%
Morgan Stanley
6
Morgan Stanley
New York
$854K +$507K +15,794 +317%
Ameriprise
7
Ameriprise
Minnesota
$659K -$78.2K -2,437 -13%
Janney Montgomery Scott
8
Janney Montgomery Scott
Pennsylvania
$632K +$145K +4,520 +42%
Bank of New York Mellon
9
Bank of New York Mellon
New York
$582K +$120K +3,741 +36%
DC
10
Diametric Capital
Massachusetts
$559K -$104K -3,240 -19%
SIC
11
Salem Investment Counselors
North Carolina
$461K -$64.2K -2,000 -15%
Citadel Advisors
12
Citadel Advisors
Florida
$436K +$30.3K +943 +10%
Charles Schwab
13
Charles Schwab
California
$425K
Renaissance Technologies
14
Renaissance Technologies
New York
$411K +$38.5K +1,200 +14%
SI
15
Stephens Inc
Arkansas
$375K
QC
16
Quadrature Capital
United Kingdom
$281K -$282K -8,775 -56%
T. Rowe Price Associates
17
T. Rowe Price Associates
Maryland
$226K +$176K +5,483 New
Barclays
18
Barclays
United Kingdom
$219K +$149K +4,653 +681%
N
19
Nuveen
North Carolina
$209K +$163K +5,089 New
UBS Group
20
UBS Group
Switzerland
$180K +$68.2K +2,124 +94%
Bank of America
21
Bank of America
North Carolina
$155K +$43K +1,340 +55%
RhumbLine Advisers
22
RhumbLine Advisers
Massachusetts
$124K -$3.37K -105 -3%
Deutsche Bank
23
Deutsche Bank
Germany
$119K +$85.2K +2,654 +1,066%
JP Morgan Chase
24
JP Morgan Chase
New York
$114K +$9.92K +309 +13%
Lazard Asset Management
25
Lazard Asset Management
New York
$107K +$3.37K +105 +4%

SMTI Hedge Fund Activity: Q4 2023 in Review

47 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Sanara MedTech (SMTI) for Q4 2023, worth a combined $28.6M — up 45% from $19.8M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new SMTI positions and 0 closed out — a net gain of 4 holders — while 21 added to existing stakes and 13 trimmed.

The largest buyer was BlackRock, adding an estimated $765K. The largest seller was Quadrature Capital, cutting an estimated $282K.

  • 47 institutional investors held Sanara MedTech (SMTI) as of Q4 2023, up from 43 in Q3 2023.
  • Funds reported $28.6M of Sanara MedTech stock for Q4 2023, up 45% quarter-over-quarter.
  • 4 funds opened new Sanara MedTech positions in Q4 2023 and 0 closed out, a net change of +4 holders.
  • The largest Sanara MedTech buyer in Q4 2023 was BlackRock, an estimated $765K added.
  • The largest Sanara MedTech seller in Q4 2023 was Quadrature Capital, an estimated $282K sold.

Based on aggregated 13F filings for Q4 2023.